Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Terri B, Hyde"'
Publikováno v:
BMJ Medicine, Vol 3, Iss 1 (2024)
Objective To analyse progress in global vaccination against human papillomavirus (HPV) during the covid-19 pandemic, with a particular focus on equity.Design Descriptive study of World Health Organization-Unicef vaccination coverage estimates.Setting
Externí odkaz:
https://doaj.org/article/6627a05e91cc4495b798c2758da0fcf0
Autor:
Heidi M. Soeters, Reena H. Doshi, Monica Fleming, Oluwasegun Joel Adegoke, Uzoamaka Ajene, Brooke Noel Aksnes, Sarah Bennett, Erin F. Blau, Julie Garon Carlton, Sara Clements, Laura Conklin, Melissa Dahlke, Lindsey M. Duca, Leora R. Feldstein, Jane F. Gidudu, Gavin Grant, Margaret Hercules, Ledor S. Igboh, Atsuyoshi Ishizumi, Sara Jacenko, Yinka Kerr, Nuadum M. Konne, Shibani Kulkarni, Archana Kumar, Kathryn E. Lafond, Eugene Lam, Ashley T. Longley, Margaret McCarron, Apophia Namageyo-Funa, Nancy Ortiz, Jaymin C. Patel, Robert T. Perry, Dimitri Prybylski, Prianca Reddi, Omar Salman, Courtney N. Sciarratta, Talya Shragai, Akshita Siddula, Ester Sikare, Dieula Delissaint Tchoualeu, Denise Traicoff, Alexandra Tuttle, Kerton R. Victory, Aaron Wallace, Kirsten Ward, Man Kai Alyssa Wong, Weigong Zhou, W. William Schluter, David L. Fitter, Anthony Mounts, Joseph S. Bresee, Terri B. Hyde
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 13, Pp 208-216 (2022)
The US Centers for Disease Control and Prevention (CDC) supports international partners in introducing vaccines, including those against SARS-CoV-2 virus. CDC contributes to the development of global technical tools, guidance, and policy for COVID-19
Externí odkaz:
https://doaj.org/article/a28160f7d8924c3fb7eb5a3ceaf22d3d
Autor:
Reena H. Doshi, Stephanie C. Garbern, Shibani Kulkarni, Shiromi M. Perera, Monica K. Fleming, Rigobert Fraterne Muhayangabo, Arsene Balene Ombeni, Dieula Delissaint Tchoualeu, Ruth Kallay, Elizabeth Song, Jasmine Powell, Monique Gainey, Bailey Glenn, Ruffin Mitume Mutumwa, Stephane Hans Bateyi Mustafa, Giulia Earle-Richardson, Hongjiang Gao, Neetu Abad, Gnakub Norbert Soke, David L. Fitter, Terri B. Hyde, Dimitri Prybylski, Adam C. Levine, Mohamed F. Jalloh, Eta Ngole Mbong
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionDuring the 2018–2020 Ebola virus disease (EVD) outbreak in the eastern part of the Democratic Republic of the Congo (DRC), prevention and control measures, such as Ebola vaccination were challenging by community mistrust. We aimed to un
Externí odkaz:
https://doaj.org/article/a39bedee5ecd4c33bd630ce9712c30e7
Autor:
Sylvain F. Nkwenkeu, Mohamed F. Jalloh, Jenny A. Walldorf, Robert L. Zoma, Felix Tarbangdo, Soukeynatou Fall, Sansan Hien, Roland Combassere, Cesaire Ky, Ludovic Kambou, Alpha Oumar Diallo, Akshaya Krishnaswamy, Flavien H. Aké, Cynthia Hatcher, Jaymin C. Patel, Isaïe Medah, Ryan T. Novak, Terri B. Hyde, Heidi M. Soeters, Imran Mirza
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Meningococcal serogroup A conjugate vaccine (MACV) was introduced in 2017 into the routine childhood immunization schedule (at 15–18 months of age) in Burkina Faso to help reduce meningococcal meningitis burden. MACV was schedul
Externí odkaz:
https://doaj.org/article/9e04871cd0ac4522b05652eb25d342c5
Autor:
Ryan T. Novak, Heidi M Soeters, Cynthia Hatcher, Jenny A. Walldorf, Alpha Oumar Diallo, Isaïe Medah, Robert L. Zoma, Jaymin C. Patel, Terri B. Hyde, Ludovic Kambou, Félix Tarbangdo, Brooke Noel Aksnes, Mohamed F Jalloh, Imran Mirza, Sansan Hien, Sylvain F. Nkwenkeu, Soukeynatou Fall, Flavien Aké, Cesaire Ky
Publikováno v:
Vaccine
Highlights • Caregivers were motivated to vaccinate their children against measles and meningitis. • Motivations were driven by vaccine communication and perceived disease protection. • Health workers were trusted sources of vaccine information
Autor:
Rania A. Tohme, Jeannot François, Kathleen Wannemuehler, Preetha Iyengar, Amber Dismer, Paul Adrien, Terri B. Hyde, Barbara J. Marston, Kashmira A. Date, Eric D. Mintz, Mark A. Katz
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 6, Pp 984-991 (2015)
In 2013, the first government-led oral cholera vaccination (OCV) campaign in Haiti was implemented in Petite Anse and Cerca Carvajal. To evaluate vaccination coverage, barriers to vaccination, and adverse events following vaccination, we conducted a
Externí odkaz:
https://doaj.org/article/5cec4427b303457796d181611fa7f731
Autor:
Virginia Senkomago, Denise Duran, Anagha Loharikar, Terri B. Hyde, Lauri E. Markowitz, Elizabeth R. Unger, Mona Saraiya
Publikováno v:
Emerging Infectious Diseases, Vol 23, Iss 13, Pp - (2017)
Cervical cancer incidence and mortality rates are high, particularly in developing countries. Most cervical cancers can be prevented by human papillomavirus (HPV) vaccination, screening, and timely treatment. The US Centers for Disease Control and Pr
Externí odkaz:
https://doaj.org/article/057d4a0b9be84be8b798f44b5f45d396
Publikováno v:
Emerging Infectious Diseases, Vol 23, Iss 13, Pp - (2017)
Countries must be prepared to respond to public health threats associated with emergencies, such as natural disasters, sociopolitical conflicts, or uncontrolled disease outbreaks. Rapid vaccination of populations vulnerable to epidemic-prone vaccine-
Externí odkaz:
https://doaj.org/article/38ca31e439a2422280839112ef6a8b33
Publikováno v:
Vaccine
Highlights • Seasonal influenza vaccine post-introduction evaluations (IPIEs) were conducted. • Critical implementation issues were highlighted across three middle-income countries. • Health workers have an important dual role in seasonal influ
Autor:
Daniel E Velasquez-Portocarrero, Xiaoqian Wang, Margaret M Cortese, Cynthia J Snider, Abhijeet Anand, Veronica P Costantini, Md Yunus, Asma B Aziz, Warda Haque, Umesh Parashar, Zufan Sisay, Heidi M Soeters, Terri B Hyde, Baoming Jiang, Khalequ Zaman
Publikováno v:
The Lancet. Infectious diseases. 22(11)
A head-to-head comparison of the most widely used oral rotavirus vaccines has not previously been done, particularly in a high child mortality setting. We therefore aimed to compare the immunogenicity of RotaTeq (Merck, Kenilworth, NJ, USA) and Rotar